Hemostats & Tissue Sealants Market by Product Type (Hemostats, Tissue sealants), Application (Burn & Trauma Cases, Cardiovascular, General Surgeries), End User - Global Forecast 2024-2030

[183 Pages Report] The Hemostats & Tissue Sealants Market size was estimated at USD 10.50 billion in 2023 and expected to reach USD 11.78 billion in 2024, at a CAGR 12.33% to reach USD 23.72 billion by 2030.

Hemostats & tissue sealants are used in several surgical disciplines to stop bleeding mechanically or by augmenting the coagulation cascade. Tissue sealants are products that bind to and close cuts in tissue. The increasing aging population, the rising prevalence of chronic conditions and diseases, and the need for timely surgeries are expected to drive the market's growth. Several government initiatives to focus on wound closure management and easy availability of hemostats & tissue sealants are the market growth factors. However, the higher cost of surgical procedures, the rising prices of surgical products and treatments, and strict regulations regarding the utilization of hemostats & tissue sealants hamper the market growth. Technological advancement in hemostats & tissue sealants products and increasing use of biopolymer-based hemostats are expected to create a significant market opportunity in the forecasted period.

The Americas has a significant presence in the hemostats & tissue sealants market owing to the growing prevalence of cardiovascular diseases, diabetes, and cancer and increasing health expenditure within the region. According to the National Health Expenditure Accounts, U.S. healthcare spending increased by 2.7% in 2021, reaching USD 4.3 trillion or USD 12,914 per person to address rising healthcare issues. The launch of advanced and innovative products, the rising number of surgeries, and the increasing demand for more effective and quicker healing post-surgery are enhancing the demand for hemostats & tissue sealants in the European region. The proliferating approvals and clearance of hemostats & tissue sealants have expanded the availability of new products in Europe. The hemostats & tissue sealants market is growing in Asia-Pacific due to increased medical tourism and surgical procedures volume.

The market dynamics represent an ever-changing landscape of the Hemostats & Tissue Sealants Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

• Market Drivers
  • Prevalence of chronic disorders and need for timely surgeries
  • Rise of biopolymer-based disposable hemostats
  • Availability of hemostats through trusted online medical device channels
• Market Restraints
  • Low outlining quality and high costs of surgical sealants
• Market Opportunities
  • Introduction of new-generation tissue sealants and hemostatic agents
  • Initiatives focusing on wound healing and closure management
• Market Challenges
  • Strict standards regarding the utilization of hemostats & tissue sealants

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Hemostats & Tissue Sealants Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Hemostats & Tissue Sealants Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Hemostats & Tissue Sealants Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

• Olympus Launches EndoClot Hemostatic Agents and Submucosal Injection Agent in European Markets

  Olympus, a global leader in medical innovation, has recently launched two advanced medical tools in European markets that are set to revolutionize hemostats and tissue sealants. The first tool, EndoClot, is a hemostatic agent designed to quickly stop bleeding in various medical procedures, reducing the need for surgical intervention and enhancing patient care. The second tool, Submucosal Injection Agent, is a highly innovative tissue sealant used in endoscopic procedures to support the prevention of further bleeding and enable effective wound healing. Olympus has consistently shown a commitment to driving innovation in the medical industry, and these products are a testament to their dedication to advancing patient care. [Published On: April 20, 2023]

• Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations

  Corza Medical has signed a definitive agreement to acquire Takeda's Tachosil manufacturing operations. Tachosil is a surgical patch used for hemostasis and tissue sealing. The acquisition is expected to strengthen Corza's position as a leading player in the market for hemostats and tissue sealants. The companies have not disclosed the financial terms of the deal. The acquisition aligns with Corza's mission of developing innovative medical solutions to improve patient outcomes. With the addition of Tachosil, Corza will be able to enhance its existing portfolio and offer healthcare providers with more options for managing surgical bleeding and tissue closure during surgical procedures. [Published On: April 06, 2023]

• Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat

  Advamedica recently announced the exciting news of FDA clearance for their innovative Hemostat & Tissue Sealant products. This is a game-changing development, as the new products offer exceptional hemostatic and sealant capabilities, while also being safe and easy to use. With this clearance, Advamedica can now bring their products to market and provide healthcare professionals with the tools they need to improve patient outcomes. The company has worked tirelessly to develop these products, and their hard work has paid off with FDA recognition of their safety and effectiveness. As a leader in hemostats and tissue sealants, Advamedica is poised to make a significant impact in the medical field and provide a solution to a critical medical need. [Published On: March 21, 2023]

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Hemostats & Tissue Sealants Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

The report delves into recent significant developments in the Hemostats & Tissue Sealants Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Medical Solutions Group PLC, Aegis Lifesciences Private Limited., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., CooperSurgical, Inc., CryoLife, Inc., CSL Behring, CuraMedical B.V., Grifols, S.A., Hemostasis, LLC, Hologic, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KAKEN PHARMACEUTICAL CO., LTD., KATSAN Katgüt Sanayi ve Tic. A.Ş., Medline Industries, LP., Medtronic PLC, Olympus Corporation, Owens & Minor, Pfizer, Inc., Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., Vivostat A/S, and Zimmer Biomet.

This research report categorizes the Hemostats & Tissue Sealants Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product Type
  • Hemostats
    • Active Hemostats
    • Flowable Hemostats
    • Mechanical Hemostats
  • Tissue sealants
    • Fibrin Sealants
    • Synthetic Sealants
• Application
  • Burn & Trauma Cases
  • Cardiovascular
  • General Surgeries
  • Neurological
  • Orthopedic
  • Reconstructive Surgeries
  • Urological
• End User
  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

1. What is the current market size and projected growth?
2. Which products, segments, applications, and regions offer promising investment opportunities?
3. What are the prevailing technology trends and regulatory frameworks?
4. What is the market share and positioning of the leading vendors?
5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?